Geneos Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$621K Sell
7,939
-8,153
-51% -$638K 0.02% 647
2025
Q1
$1.17M Buy
16,092
+9,132
+131% +$662K 0.02% 624
2024
Q4
$515K Sell
6,960
-166
-2% -$12.3K 0.02% 579
2024
Q3
$470K Buy
7,126
+119
+2% +$7.85K 0.02% 577
2024
Q2
$647K Sell
7,007
-199
-3% -$18.4K 0.03% 439
2024
Q1
$689K Sell
7,206
-139
-2% -$13.3K 0.03% 422
2023
Q4
$560K Buy
7,345
+100
+1% +$7.63K 0.03% 460
2023
Q3
$502K Buy
7,245
+170
+2% +$11.8K 0.03% 466
2023
Q2
$667K Sell
7,075
-379
-5% -$35.8K 0.04% 400
2023
Q1
$617K Buy
7,454
+312
+4% +$25.8K 0.04% 402
2022
Q4
$533K Buy
7,142
+78
+1% +$5.82K 0.03% 409
2022
Q3
$583K Sell
7,064
-1,499
-18% -$124K 0.04% 362
2022
Q2
$833K Sell
8,563
-325
-4% -$31.6K 0.04% 369
2022
Q1
$1.05M Sell
8,888
-1,780
-17% -$209K 0.04% 340
2021
Q4
$1.38M Buy
10,668
+2,237
+27% +$290K 0.05% 313
2021
Q3
$946K Sell
8,431
-69
-0.8% -$7.74K 0.04% 400
2021
Q2
$906K Buy
8,500
+5,759
+210% +$614K 0.04% 389
2021
Q1
$261K Hold
2,741
0.01% 856
2020
Q4
$225K Buy
2,741
+682
+33% +$56K 0.01% 789
2020
Q3
$159K Sell
2,059
-1,943
-49% -$150K 0.01% 766
2020
Q2
$268K Hold
4,002
0.01% 577
2020
Q1
$264K Buy
4,002
+300
+8% +$19.8K 0.02% 529
2019
Q4
$289K Hold
3,702
0.02% 571
2019
Q3
$268K Hold
3,702
0.02% 560
2019
Q2
$227K Hold
3,702
0.01% 620
2019
Q1
$236K Hold
3,702
0.02% 589
2018
Q4
$185K Hold
3,702
0.01% 629
2018
Q3
$214K Buy
3,702
+426
+13% +$24.6K 0.01% 617
2018
Q2
$158K Hold
3,276
0.01% 623
2018
Q1
$152K Sell
3,276
-57
-2% -$2.65K 0.01% 612
2017
Q4
$125K Sell
3,333
-1,200
-26% -$45K 0.01% 676
2017
Q3
$165K Hold
4,533
0.02% 563
2017
Q2
$178K Sell
4,533
-36
-0.8% -$1.41K 0.02% 527
2017
Q1
$143K Sell
4,569
-69
-1% -$2.16K 0.01% 560
2016
Q4
$144K Buy
4,638
+312
+7% +$9.69K 0.02% 527
2016
Q3
$173K Buy
4,326
+150
+4% +$6K 0.02% 475
2016
Q2
$137K Hold
4,176
0.02% 520
2016
Q1
$125K Buy
+4,176
New +$125K 0.02% 532